首页> 外文期刊>Frontiers in Laboratory Medicine >p62/SQSTM1: A potential molecular target for treatment of atherosclerosis
【24h】

p62/SQSTM1: A potential molecular target for treatment of atherosclerosis

机译:p62 / SQSTM1:治疗动脉粥样硬化的潜在分子靶标

获取原文
       

摘要

Atherosclerosis is a chronic inflammatory disease, and multiple signaling pathways participate in its pathophysiological process. It has been generally recognized that macrophage autophagy is involved in the development of atherosclerosis. As a multifunctional ubiquitin-binding protein, p62/SQSTM1 participates in many core processes of autophagy in macrophages. Therefore, it is significant to investigate the role of p62 in atherosclerosis on the basis of autophagy theory. In this paper, we will review the latest research about p62 protein in atherosclerosis, in order to provide a reference for further understanding of the occurrence and development of atherosclerosis.
机译:动脉粥样硬化是一种慢性炎症性疾病,多种信号通路参与其病理生理过程。人们普遍认识到巨噬细胞自噬与动脉粥样硬化的发展有关。作为多功能泛素结合蛋白,p62 / SQSTM1参与巨噬细胞自噬的许多核心过程。因此,根据自噬理论研究p62在动脉粥样硬化中的作用具有重要意义。在本文中,我们将回顾有关动脉粥样硬化中p62蛋白的最新研究,以便为进一步了解动脉粥样硬化的发生和发展提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号